SARS-CoV-2 infection after vaccination in patients with inflammatory rheumatic and musculoskeletal diseases

Saskia Lawson-Tovey; Kimme L Hyrich; Laure Gossec; Anja Strangfeld; Loreto Carmona; Bernd Raffeiner; Gözde Kübra Yardımcı; Ludovic Trefond; Nicolas Roux; Ana Rodrigues; Charalampos Papagoras; Elsa F Mateus; Xavier Mariette; Pedro M Machado

doi:10.1136/annrheumdis-2021-221217

SARS-CoV-2 infection after vaccination in patients with inflammatory rheumatic and musculoskeletal diseases

Ann Rheum Dis. 2022 Jan;81(1):145-150. doi: 10.1136/annrheumdis-2021-221217. Epub 2021 Sep 6.

Authors

Saskia Lawson-Tovey^{1

2}, Kimme L Hyrich^{2

3}, Laure Gossec^{4

5}, Anja Strangfeld⁶, Loreto Carmona⁷, Bernd Raffeiner⁸, Gözde Kübra Yardımcı⁹, Ludovic Trefond¹⁰, Nicolas Roux¹¹, Ana Rodrigues^{12

13}, Charalampos Papagoras¹⁴, Elsa F Mateus^{15

16}, Xavier Mariette¹⁷, Pedro M Machado^{18

19

20}

Affiliations

¹ Centre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, University of Manchester, Manchester, UK.
² National Institute for Health Research Manchester Biomedical Research Centre, Manchester Academic Health Science Centre, Manchester, UK.
³ Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, University of Manchester, Manchester, UK.
⁴ Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
⁵ Rheumatology Department, Pitié-Salpêtrière Hospital, Sorbonne Université, AP-HP, Paris, France.
⁶ German Rheumatism Research Center (DRFZ Berlin), Epidemiology Unit, Berlin, Germany.
⁷ Instituto de Salud Musculoesquelética (INMUSC), Madrid, Spain.
⁸ Department of Rheumatology, Central Hospital of Bolzano, Bolzano, Italy.
⁹ Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
¹⁰ CHU Clermont Ferrand, Service de Médecine Interne, Hôpital Gabriel Montpied, Inserm U1071, INRA USC2018, M2iSH, Université Clermont Auvergne, Clermont-Ferrand, France.
¹¹ Service de Rhumatologie, Hôpital Robert Schuman, Metz, France.
¹² Reuma.pt, Sociedade Portuguesa de Reumatologia, Lisboa, Portugal.
¹³ EpiDoC Unit, CEDOC, CHRC Campus Nova Medical School, Lisboa, Portugal.
¹⁴ First Department of Internal Medicine, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.
¹⁵ Portuguese League Against Rheumatic Diseases (LPCDR), Lisbon, Portugal.
¹⁶ Standing Committee of People with Arthritis/Rheumatism in Europe (PARE), European League Against Rheumatism, Zurich, Switzerland.
¹⁷ Department of Rheumatology, Université Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Hopital Bicetre, Le Kremlin-Bicetre, France.
¹⁸ Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, London, UK p.machado@ucl.ac.uk.
¹⁹ National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK.
²⁰ Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, London, UK.

PMID: 34489305
DOI: 10.1136/annrheumdis-2021-221217

No abstract available

Keywords: COVID-19; epidemiology; vaccination.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Aged, 80 and over
Antirheumatic Agents / therapeutic use*
COVID-19 / epidemiology*
COVID-19 / prevention & control*
COVID-19 Vaccines*
Comorbidity
Female
Humans
Hypertension / epidemiology
Male
Middle Aged
Registries
Rheumatic Diseases / drug therapy*
Vaccination

Substances

Antirheumatic Agents
COVID-19 Vaccines

Supplementary concepts

COVID-19 breakthrough infections